Standardized Definitions for Efficacy End Points for Adjuvant Trials—The Updated STEEP Criteria

This Viewpoint discusses how the inclusion or exclusion of certain events in the standardization of clinical trial end points can affect the interpretation of results.

Authors

Institutions

Publication Details

Journal
JAMA Oncology
Published
2024-09-19
DOI
https://doi.org/10.1001/jamaoncol.2024.3888
Citations
1
Primary Topic
Statistical Methods in Clinical Trials
Type
article
Field-Weighted Citation Impact
0.71
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Standardized Definitions for Efficacy End Points for Adjuvant Trials—The Updated STEEP Criteria

Dominik Hlauschek, Michael Gnant, Christian Fesl
1 citations
JAMA Oncology
Statistical Methods in Clinical Trials
0.71
article

Standardized Definitions for Efficacy End Points for Adjuvant Trials—The Updated STEEP Criteria

Dominik Hlauschek, Michael Gnant, Christian Fesl
article en
1 citations

Abstract

This Viewpoint discusses how the inclusion or exclusion of certain events in the standardization of clinical trial end points can affect the interpretation of results.

JAMA OncologyVol. 10(11)
Comprehensive Cancer Center Vienna (AT), Austrian Breast & Colorectal Cancer Study Group (AT), Medical University of Vienna (AT)
Reduced inequalities
Openalex Percentile: Top 26%
Statistical Methods in Clinical Trials
0.71
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.